
NHI Stock Forecast & Price Target
NHI Analyst Ratings
Bulls say
National Health Investors Inc. is projected to experience significant financial growth, with expectations of 2.2% year-over-year normalized Funds From Operations per share (FFOps) growth in 2024, escalating to 5.0% in 2025. The company is anticipated to achieve an average annual normalized FFOps growth rate of 4.1% from 2024 to 2029, driven by improving fundamentals and enhanced operator performance. Additionally, the potential growth of the Senior Housing Operating Portfolio, currently at 4.5% of the overall portfolio, to 30% within five years, coupled with favorable lease negotiations, suggests a positive trajectory for shareholder value in the coming years.
Bears say
National Health Investors Inc has experienced an 18% decline in stock value over the past three months, outpacing the VNQ's 10% decline, while also trading at a premium relative to its historical averages. The company faces challenges with lower expected earnings growth due to difficulties with operators, such as Discovery, which has underperformed against cash flow projections, and potential unfavorable rent restructurings as the sector recovers from the pandemic. Additionally, a revision of the 2025 Funds from Operations (FFO) estimate indicates declining performance expectations, with estimated occupancy rates for the Senior Housing Operating Portfolio remaining below targets, further contributing to a cautious outlook on the stock.
This aggregate rating is based on analysts' research of National Health Investors and is not a guaranteed prediction by Public.com or investment advice.
NHI Analyst Forecast & Price Prediction
Start investing in NHI
Order type
Buy in
Order amount
Est. shares
0 shares